94
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Development and Analytical Validation of a Targeted Next-Generation Sequencing Panel to Detect Actionable Mutations for Targeted Therapy

, , ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Pages 2423-2431 | Published online: 07 Apr 2021

Figures & data

Table 1 Five HapMap Normal Samples and Their Dilution Ratios in Five Diluted Samples for SNV Validation

Table 2 Performance of SNV Calling at AF ≥5% for Five Diluted Samples at Different Sequencing Depths

Figure 1 Detected AF vs expected AF for five SNV diluted samples (AE) and the reference standard sample HD701 (F).

Figure 1 Detected AF vs expected AF for five SNV diluted samples (A–E) and the reference standard sample HD701 (F).

Table 3 Performance of INDEL Calling at AF ≥2% for Five Diluted Samples at Different Sequencing Depths

Figure 2 Detected AF vs expected AF for five INDEL diluted samples. Please note that the INDELs in these five diluted samples are plotted together.

Figure 2 Detected AF vs expected AF for five INDEL diluted samples. Please note that the INDELs in these five diluted samples are plotted together.

Table 4 The Validation Results of Reference Standard Sample HD701 at the Sequencing Depth of 500X for Confirmed Hotspot SNVs and INDELs

Figure 3 The normalized mean depths for all the targeted regions for different validation samples.

Figure 3 The normalized mean depths for all the targeted regions for different validation samples.